192 related articles for article (PubMed ID: 38178583)
1. BRCC36 Deubiquitinates HMGCR to Regulate the Interplay Between Ferroptosis and Pyroptosis.
Wang H; Shu L; Lv C; Liu N; Long Y; Peng X; Ling H; Tao T; Tang J; Cheng Y; Liu S; Xiao D; Tao Y
Adv Sci (Weinh); 2024 Mar; 11(11):e2304263. PubMed ID: 38178583
[TBL] [Abstract][Full Text] [Related]
2. β-Sitosterol Alleviates the Proliferation and Migration of Cystitis Glandularis-Associated Cells by Targeting HMGCR to Induce NLRP3-Dependent Pyroptosis.
Qiu D; Gao L; Zhang S; Zhu Y; Lin G
Discov Med; 2024 Jan; 36(180):150-159. PubMed ID: 38273755
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis, Pyroptosis, and Ferroptosis Conspiringly Induce Immunosuppressive Hepatocellular Carcinoma Microenvironment and γδ T-Cell Imbalance.
Hu Y; Chen D; Hong M; Liu J; Li Y; Hao J; Lu L; Yin Z; Wu Y
Front Immunol; 2022; 13():845974. PubMed ID: 35444645
[TBL] [Abstract][Full Text] [Related]
4. Autophagy, Ferroptosis, Apoptosis and Pyroptosis in Metabolic Dysfunction-Associated Steatotic Liver Disease.
Zhao S; Guo Y; Yin X
Front Biosci (Landmark Ed); 2024 Jan; 29(1):30. PubMed ID: 38287834
[TBL] [Abstract][Full Text] [Related]
5. Sorcin regulate pyroptosis by interacting with NLRP3 inflammasomes to facilitate the progression of hepatocellular carcinoma.
Li Z; Yang Z; Zhu Y; Fu C; Li N; Peng F
Cell Death Dis; 2023 Oct; 14(10):678. PubMed ID: 37833249
[TBL] [Abstract][Full Text] [Related]
6. Ferroptosis, pyroptosis and necroptosis in hepatocellular carcinoma immunotherapy: Mechanisms and immunologic landscape (Review).
Liu RJ; Yu XD; Yan SS; Guo ZW; Zao XB; Zhang YS
Int J Oncol; 2024 Jun; 64(6):. PubMed ID: 38757345
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and mitochondria-localized iridium (III) complexes induce cell death through pyroptosis and ferroptosis pathways.
Hu H; Zhang F; Sheng Z; Tian S; Li G; Tang S; Niu Y; Yang J; Liu Y
Eur J Med Chem; 2024 Mar; 268():116295. PubMed ID: 38437750
[TBL] [Abstract][Full Text] [Related]
8. Combination of ferroptosis and pyroptosis to construct a prognostic classifier and predict immune landscape, chemotherapeutic efficacy and immunosuppressive molecules in hepatocellular carcinoma.
Xu L; Zheng Q; Liu W
BMC Cancer; 2022 Mar; 22(1):229. PubMed ID: 35236323
[TBL] [Abstract][Full Text] [Related]
9. HSP90 interacts with HMGCR and promotes the progression of hepatocellular carcinoma.
Dong L; Xue L; Zhang C; Li H; Cai Z; Guo R
Mol Med Rep; 2019 Jan; 19(1):524-532. PubMed ID: 30483734
[TBL] [Abstract][Full Text] [Related]
10. Novel insights into the interplay between m6A modification and programmed cell death in cancer.
Chen J; Ye M; Bai J; Hu C; Lu F; Gu D; Yu P; Tang Q
Int J Biol Sci; 2023; 19(6):1748-1763. PubMed ID: 37063421
[TBL] [Abstract][Full Text] [Related]
11. The applications of nanozymes in cancer therapy: based on regulating pyroptosis, ferroptosis and autophagy of tumor cells.
Zhang Y; Yu W; Chen M; Zhang B; Zhang L; Li P
Nanoscale; 2023 Jul; 15(29):12137-12156. PubMed ID: 37377098
[TBL] [Abstract][Full Text] [Related]
12. Gene body hypomethylation of pyroptosis-related genes NLRP7, NLRP2, and NLRP3 facilitate non-invasive surveillance of hepatocellular carcinoma.
Zhang H; Dong P; Fan H; Liang H; Zhang K; Zhao Y; Guo S; Schrodi SJ; Fan Y; Zhang D
Funct Integr Genomics; 2023 Jun; 23(2):198. PubMed ID: 37273114
[TBL] [Abstract][Full Text] [Related]
13. TMEM147 aggravates the progression of HCC by modulating cholesterol homeostasis, suppressing ferroptosis, and promoting the M2 polarization of tumor-associated macrophages.
Huang J; Pan H; Sun J; Wu J; Xuan Q; Wang J; Ke S; Lu S; Li Z; Feng Z; Hua Y; Yu Q; Yin B; Qian B; Zhou M; Xu Y; Bai M; Zhang Y; Wu Y; Ma Y; Jiang H; Dai W
J Exp Clin Cancer Res; 2023 Oct; 42(1):286. PubMed ID: 37891677
[TBL] [Abstract][Full Text] [Related]
14. Regulation of oxidized LDL-induced inflammatory process through NLRP3 inflammasome activation by the deubiquitinating enzyme BRCC36.
Singh M; Kumari B; Yadav UCS
Inflamm Res; 2019 Dec; 68(12):999-1010. PubMed ID: 31485755
[TBL] [Abstract][Full Text] [Related]
15. The emerging roles of nitric oxide in ferroptosis and pyroptosis of tumor cells.
He Q; Qu M; Xu C; Shi W; Hussain M; Jin G; Zhu H; Zeng LH; Wu X
Life Sci; 2022 Feb; 290():120257. PubMed ID: 34952041
[TBL] [Abstract][Full Text] [Related]
16. Programmed Cell Death Tunes Tumor Immunity.
Liu J; Hong M; Li Y; Chen D; Wu Y; Hu Y
Front Immunol; 2022; 13():847345. PubMed ID: 35432318
[TBL] [Abstract][Full Text] [Related]
17. Autophagy activation is required for N6-methyladenosine modification to regulate ferroptosis in hepatocellular carcinoma.
Li Y; Guo M; Qiu Y; Li M; Wu Y; Shen M; Wang Y; Zhang F; Shao J; Xu X; Zhang Z; Zheng S
Redox Biol; 2024 Feb; 69():102971. PubMed ID: 38056309
[TBL] [Abstract][Full Text] [Related]
18. Regulation of programmed cell death by Brd4.
Hu J; Pan D; Li G; Chen K; Hu X
Cell Death Dis; 2022 Dec; 13(12):1059. PubMed ID: 36539410
[TBL] [Abstract][Full Text] [Related]
19. Ferroptosis in tumors and its relationship to other programmed cell death: role of non-coding RNAs.
Zhang Q; Fan X; Zhang X; Ju S
J Transl Med; 2023 Jul; 21(1):514. PubMed ID: 37516888
[TBL] [Abstract][Full Text] [Related]
20. Polyphyllin I induced ferroptosis to suppress the progression of hepatocellular carcinoma through activation of the mitochondrial dysfunction via Nrf2/HO-1/GPX4 axis.
Yang R; Gao W; Wang Z; Jian H; Peng L; Yu X; Xue P; Peng W; Li K; Zeng P
Phytomedicine; 2024 Jan; 122():155135. PubMed ID: 37856990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
